Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
A combination including Inula racemosa, Commiphora mukul, Centella asiatica, and Hypericum perforatum showed significant correction in lipid profile (including triglycerides), blood pressure, and psychological factors like anxiety and depression over 6 months [PMID:22556998].
Root extract demonstrated hepatoprotective potential against diethylnitrosamine (DEN) induced hepatic damage in a murine model [PMID:40638963].
Isoalantolactone showed dose-dependent reduction in cell viability and induction of apoptosis in testicular cancer cells in vitro [PMID:39382942].
Aqueous root extract improved survival of Normal Kidney Epithelium cells and increased whole-body survival in mice exposed to gamma-radiation [PMID:30998083].
Methanol extract of Inula racemosa showed 90.33% mycelial inhibition against the brown spot pathogen Bipolaris oryzae in vitro [PMID:38977720].
Synthèse des preuves
Sources PubMed
- 1.PMID: 9855567 (1998) — Botanical influences on cardiovascular disease. · Alternative medicine review : a journal of clinical therapeutic
- 2.PMID: 34600078 (2022) — Ethnopharmacology, phytochemistry, agrotechnology, and conservation of Inula racemosa Hook f. - A critically endangered medicinal plant of the western Himalaya. · Journal of ethnopharmacology
- 3.PMID: 24288468 (2013) — Targeting apoptosis pathways in cancer with alantolactone and isoalantolactone. · TheScientificWorldJournal
- 4.PMID: 21623523 (2011) — Sesquiterpenoids from Inula racemosa. · Journal of Asian natural products research
- 5.PMID: 22556998 (2000) — Individuals at Risk of Coronary Heart Disease (CHD), its Prevention and Management by an Indigenous Compound.